Severe infusion reactions to tocilizumab in young children with systemic juvenile idiopathic arthritis
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 2
Abstract
Objective: Tocilizumab (TCZ) is the first-line agent against systemic juvenile idiopathic arthritis (sJIA) refractory to glucocorticoids. However, some patients discontinue TCZ because of severe infusion reactions (IRs). This study aimed to demonstrate the characteristics of patients with sJIA who develop severe IRs to TCZ, and investigate its risk factors. Method: Thirty-one patients with newly diagnosed sJIA (boys-16; girls-15) who received at least one infusion of TCZ were enrolled. Results: Four patients presented with TCZ-induced severe IRs. IRs appeared in the early phase of treatment, especially within the 10th infusion of TCZ. All of these patients were girls (IR group vs. non-IR group, p=0.043) and younger than 3 years old. The median age at initiation of TCZ in the IR group was significantly younger than that in the non-IR group (p=0.001). At disease onset, more patients in the IR group (75%) were complicated by macrophage activation syndrome than those in the non-IR group (11%, p=0.016). The dose of TCZ per kg was not different between the groups. However, the dose per m2 was less in the IR group than in the non-IR group (212 vs. 252 mg/m2 , p=0.052). In the IR group, except for one patient, anti-TCZ IgG and/or anti-TCZ IgE antibodies were detected. Conclusions: Risk factors of TCZ-induced severe IRs are female sex, age younger than 3 years old, and onset with macrophage activation syndrome. An optimal regimen of induction of remission with TCZ in such patients should be established.
Authors and Affiliations
Tomo Nozawa, Kenichi Nishimura, Takashi Ohya, Asami Oohara, Ryoki Hara, Shuichi Ito
Keywords
Related Articles
- EP ID EP604372
- DOI -
- Views 35
- Downloads 0
IL-17 in primary knee osteoarthritis and its relation with severity of the disease
Objective: Is to measure serum level of interleukin 17 and correlate its level with disease severity in patients with primary knee OA. Methods: Serum was collected from patients with primary knee osteoarthritis and age-...
Rheumatoid arthritis activity and severity in relation to commonly used contraceptive methods in a cohort of Egyptian female patients
Background: Objective: To study the impact/effect of commonly used contraceptive methods on rheumatoid arthritis (RA) disease activity, severity, and damage in a cohort of Egyptian female RA patients. Methods: Two hundr...
A rare complex mutation in FMF gene; genetics and treatment decisions in Familial Mediterranean Fever patients
Introduction: FMF is an autosomal-recessive autoinflammatory disease characterized by episodic, self-limiting attacks characterized by fever, abdominal pain, pleurisy, arthritis and erysipelas-like-erythema. Systemic amy...
Effect of curcuma xanthorrhiza suplementation in vitamin D3 administration towards proteinuria, serum anti-dsDNA and IL-17 levels on systemic lupus erythematosus (sle) patients with hypovitamin D
Background: Vitamin D is an immunomodulator that plays a role in immunoregulation. Curcumin is also a potential immunomodulator in several autoimmune diseases. Curcumin-vitamin D bonds in VDR have different positions, th...
Improved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
Background/Objective: We aimed at evaluating changes in habitual physical activity, disease activity and physical function following treatment with originator adalimumab (ADAORIG) in patients with Rheumatoid Arthritis (R...